Cystaduro

Cystaduro is a pharmaceutical product containing BCG (Bacillus Calmette-Guérin) bacteria, used for intravesical administration. It is primarily employed in the management of certain bladder conditions. This medication is manufactured by Medac Gesellschaft für Klinische Spezialpräparate mbH in the EU.

Cystaduro is typically used for intravesical administration to address specific bladder conditions. The primary use of BCG (Bacillus Calmette-Guérin) bacteria in this context is to stimulate the immune system within the bladder. This approach is often considered when other treatments have not been effective. Patients may wonder, 'What is Cystaduro used for?' and the answer lies in its role in managing certain bladder health issues.

When used as directed, Cystaduro may cause local irritation or inflammation at the site of administration. Some individuals might experience flu-like symptoms, such as fever or fatigue, following treatment. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Cystaduro should be handled with care to avoid contamination. It is important to follow proper hygiene practices before and after administration. Patients should inform their healthcare provider about any known allergies or medical conditions before using this medication. Always store Cystaduro as directed to maintain its effectiveness.

Cystaduro may interact with certain medications or substances, so it is important to discuss all current treatments with a healthcare provider. Alcohol and other immune-suppressing substances should be avoided during treatment. Patients should also be cautious when using other medications that affect the immune system.